CHML

N/A

Report date: 2022/05/13 14:50:30

Base Information

Drug NameCHML
Drug Alias NameCytotropic heterogeneous molecular lipids
ClassificationBiologicsNatural product/Extract > Animal extract
Mechanisms of ActionApoptosis stimulants
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesGlory
China Registration ClassN/A

Develop Information

Active CompaniesGlory
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A